3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Sponsor Class
OTHER
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
32
Observational
3
Expanded_access
2
Sponsor
Cancer Type
Sarcoma
3
Conditions
Sarcoma
3
Ovarian Neoplasms
3
Ovarian Epithelial Cancer Recurrent
1
Interventions
Gene Expression Profiling
9
Surveys and Questionnaires
7
Blood Specimen Collection
7
Surgical Procedures, Operative
6
Polymerase Chain Reaction
6
Microarray Analysis
4
Immunohistochemistry
4
Base Sequence
4
Trabectedin
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Psychiatric Rehabilitation
3
Observation
3
Drug Therapy
3
Radiotherapy
2
Patient Reported Outcome Measures
2
Molecular Diagnostic Techniques
2
Methods
2
In Situ Hybridization, Fluorescence
2
Gene Rearrangement
2
DNA Methylation
2
Amplified Fragment Length Polymorphism Analysis
2
trastuzumab deruxtecan
1
pazopanib
1
liposomal doxorubicin
1
fluorodopa F 18
1
eribulin
1
Watchful Waiting
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Sarcoma
×
Trabectedin
×
Clear all
NCT02367924
2023-06-22
YonSar
PharmaMar, Spain
Completed
130 enrolled
NCT04394728
2020-05-19
Metabol-STS
Centro di Riferimento Oncologico - Aviano
Completed
44 enrolled
NCT02793050
2019-05-10
TrObs
Italian Sarcoma Group
Completed
510 enrolled